- Home
- MVBF vs JSPR Comparison
MVBF vs JSPR Comparison
Compare MVBF & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MVBF | JSPR |
|---|---|---|
| Founded | 1997 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 351.9M | 49.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MVBF | JSPR |
|---|---|---|
| Price | $28.43 | $1.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $27.60 | $25.60 |
| AVG Volume (30 Days) | 79.3K | ★ 3.8M |
| Earning Date | 10-29-2025 | 11-10-2025 |
| Dividend Yield | ★ 2.45% | N/A |
| EPS Growth | ★ 73.99 | N/A |
| EPS | ★ 2.45 | N/A |
| Revenue | ★ $167,853,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.06 | N/A |
| P/E Ratio | $11.34 | ★ N/A |
| Revenue Growth | ★ 18.75 | N/A |
| 52 Week Low | $15.59 | $1.39 |
| 52 Week High | $28.72 | $23.11 |
Technical Indicators
Market Signals| Indicator | MVBF | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 64.74 | 43.99 |
| Support Level | $26.52 | $1.61 |
| Resistance Level | $28.72 | $1.93 |
| Average True Range (ATR) | 0.73 | 0.21 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 86.03 | 29.61 |
Price Performance
Historical ComparisonAbout MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.